RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 131 filers reported holding RELAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 13.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,917 | -27.7% | 5,222 | +7.9% | 0.00% | -33.3% |
| Q2 2023 | $60,765 | -23.7% | 4,838 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $79,682 | +1.3% | 4,838 | -8.1% | 0.00% | 0.0% |
| Q4 2022 | $78,644 | -22.9% | 5,264 | +15.5% | 0.00% | -20.0% |
| Q3 2022 | $101,962 | +33.6% | 4,558 | 0.0% | 0.01% | +66.7% |
| Q2 2022 | $76,347 | -44.0% | 4,558 | 0.0% | 0.00% | -40.0% |
| Q1 2022 | $136,421 | -75.4% | 4,558 | -74.8% | 0.01% | -37.5% |
| Q4 2021 | $555,667 | +8.2% | 18,094 | +11.1% | 0.01% | +14.3% |
| Q3 2021 | $513,435 | -13.8% | 16,284 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $595,832 | +34.3% | 16,284 | +26.9% | 0.01% | +14.3% |
| Q1 2021 | $443,568 | +13.2% | 12,831 | +36.1% | 0.01% | +16.7% |
| Q4 2020 | $391,703 | -2.4% | 9,425 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $401,411 | – | 9,425 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |